Viscosupplementation Devices Market Set to Expand at a Robust CAGR of 7.94% by 2030, According to DelveInsight Report

Companies like KiOmed Pharma, BioPolymer GmbH & Co KG, ALBOMED Registered GmbH, and Juniper Biologics are advancing Viscosupplementation Devices, improving diagnosis and patient outcomes.
DelveInsight's "Viscosupplementation Devices Market Insights, Competitive Landscape, and Market Forecast-2030 [https://www.delveinsight.com/report-store/viscosupplementation-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]" report provides a comprehensive analysis of the global viscosupplementation devices market, focusing on adoption trends, technological advancements, and market dynamics across key regions. The report examines the market's growth trajectory, offering historical and projected market sizes, revenue trends, and critical factors driving the demand for viscosupplementation devices in osteoarthritis treatment.

The report presents vital statistics on the current market landscape and highlights emerging innovations in viscosupplementation technology. It explores how advancements in hyaluronic acid formulations, combination therapies, and extended-release injectables are improving treatment efficacy, prolonging pain relief, and enhancing patient outcomes, making viscosupplementation a key non-surgical solution for osteoarthritis management.

Additionally, the report evaluates the competitive landscape, profiling major players in the global viscosupplementation devices market while also highlighting emerging technologies and solutions expected to drive market growth. It provides an in-depth review of ongoing clinical developments, regulatory progress, and novel product launches in the viscosupplementation segment. This report serves as an essential resource for understanding the evolving dynamics of the viscosupplementation devices market and forecasting its future direction.

To know in detail about the Viscosupplementation Devices market outlook, drug uptake, treatment scenario, and epidemiology trends, click here: Viscosupplementation Devices Market Forecast Report [https://www.delveinsight.com/report-store/viscosupplementation-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]

Some of the key insights of the Viscosupplementation Devices Market Report:

- The viscosupplementation devices market, valued at USD 4.08 billion in 2023, is projected to grow at a CAGR of 7.94%, reaching approximately USD 6.43 billion by 2030.

- Osteoarthritis cases in the US have been rising, reaching approximately 38.6 million in 2023, increasing the demand for viscosupplementation devices.

- North America is estimated to hold a significant revenue share in the Viscosupplementation Devices market.

- In July 2024, Anika announced the full market release of the Integrity Trademark Implant System, a regenerative hyaluronic acid-based scaffold used for repairing rotator cuff and other tendon injuries.

- Key players in the global Viscosupplementation Devices market include Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, Sanofi, Smith & Nephew, Ferring B.V., Lifecore Biomedical, LLC, LG Chem, Fidia Farmaceutici S.p.A, OrthogenRx, Bioventus, DePuy Synthes (Johnson & Johnson), Vivacy, APTISSEN, KiOmed Pharma, BioPolymer GmbH & Co KG, ALBOMED Registered GmbH, Juniper Biologics, Ono Pharmaceutical Co., Ltd., CarthroniX, Zimmer Biomet, and others.

Viscosupplementation Devices Overview

Viscosupplementation devices are used to relieve joint pain, primarily in osteoarthritis patients, by injecting hyaluronic acid (HA) into affected joints to enhance lubrication and cushioning. This minimally invasive treatment improves mobility and delays the need for surgical interventions. The growing prevalence of osteoarthritis, an aging population, and increasing patient preference for non-surgical pain management drive market growth. Advances in HA formulations, including cross-linked and combination therapies, are enhancing efficacy and patient outcomes. Additionally, rising awareness, government initiatives, and continuous innovation in viscosupplementation solutions are further boosting adoption and market expansion.

Get a Free sample for the Viscosupplementation Devices Market Forecast, Size & Share Analysis Report: https://www.delveinsight.com/report-store/viscosupplementation-devices-market [https://www.delveinsight.com/report-store/viscosupplementation-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]

Viscosupplementation Devices Market Segment Analysis:

The Viscosupplementation Devices market report offers market segment analysis for the forecast period 2024-2030, segmented into:

- Viscosupplementation Devices Market by Product Type (Single Injection, Three Injections, and Five Injections)

- Viscosupplementation Devices Market by End-User (Hospitals, Orthopedic Clinics, and Others)

- Viscosupplementation Devices Market by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Download the Viscosupplementation Devices Market Analysis report [https://www.delveinsight.com/report-store/viscosupplementation-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr] for key market trends, innovations, and growth drivers.

Viscosupplementation Devices Market Dynamics

By 2050, nearly one billion people are expected to have osteoarthritis (OA), with knee and hip OA seeing the highest increases. This rising prevalence is driving demand for viscosupplementation devices, which offer non-surgical pain relief through hyaluronic acid injections that enhance joint lubrication and function.

Market growth is further propelled by strategic industry advancements. In December 2023, Bioventus Inc. secured a nationwide contract with Aetna Trademark Medicare Advantage, enabling over 3 million members to access DUROLANE, a single-injection HA treatment for knee OA. Innovations in HA formulations, such as cross-linked HA for prolonged relief and combination therapies like Cingal, are enhancing efficacy and patient outcomes.

Despite these advancements, competition from alternative OA treatments, including pain medications, physical therapy, and PRP therapy, along with concerns about injection-related discomfort and infection risks, may limit adoption. However, the viscosupplementation market remains poised for significant expansion.

North America Set to Lead the Growth of the Global Viscosupplementation Devices Market

North America is anticipated to lead the viscosupplementation devices market, driven by the rising prevalence of osteoarthritis and an aging population. Increasing awareness programs, government initiatives, and product approvals further contribute to market growth. With a growing preference for non-surgical pain management options, viscosupplementation devices offer a minimally invasive solution for joint pain relief. Additionally, advancements in product development and regulatory approvals are expected to enhance accessibility and adoption. These factors collectively support the expansion of the viscosupplementation devices market in the region.

Viscosupplementation Devices Market Drivers

- The increasing incidence of osteoarthritis, particularly among the elderly, is driving demand for viscosupplementation devices as a non-surgical treatment option to manage joint pain and improve mobility.

- Continuous innovations, such as cross-linked HA and combination therapies (e.g., HA with corticosteroids), are enhancing treatment efficacy, prolonging pain relief, and improving patient outcomes, fueling market expansion.

Viscosupplementation Devices Market Barriers

- The presence of other non-surgical treatments, such as physical therapy, pain medications, and platelet-rich plasma (PRP) therapy, may limit the widespread adoption of viscosupplementation devices.

- Patients may experience discomfort, inflammation, or infection at the injection site, leading to hesitation in opting for viscosupplementation, thereby impacting market growth.

To learn more about Viscosupplementation Devices drivers and barriers, visit @ Viscosupplementation Devices Competitive Landscape and Market Forecast Report [https://www.delveinsight.com/report-store/viscosupplementation-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=jpr]

Table of Contents

1. Viscosupplementation Devices Market Report Introduction

2. Viscosupplementation Devices Market Executive Summary

3. Competitive Landscape

4. Regulatory Analysis

5. Viscosupplementation Devices Market Key Factors Analysis

6. Viscosupplementation Devices Market Porter's Five Forces Analysis

7. Viscosupplementation Devices Market Layout

8. Viscosupplementation Devices Market Company and Product Profiles

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

About DelveInsight

DelveInsight is a premier healthcare business consultant and market research firm, specializing in life sciences. We empower pharmaceutical companies with comprehensive end-to-end solutions designed to enhance performance and drive growth.

Our expert healthcare consulting services offer in-depth market analysis, helping businesses accelerate growth and navigate challenges with actionable, results-driven strategies.

Media Contact
Company Name: DelveInsight
Contact Person: Jatin Vimal
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=viscosupplementation-devices-market-set-to-expand-at-a-robust-cagr-of-794-by-2030-according-to-delveinsight-report]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.